Related content

Importance of Post-Implant Dosimetry in Permanent Prostate Brachytherapy

By Stock R.G.   Stone N.N.  

European Urology, Vol. 41, Iss. 4, 2002-04 ,pp. : 434-439

Elsevier

Access to resources Recommend Favorite

The Impact of Prostate Volume Following Neoadjuvant Androgen Deprivation on Quality of Life and Voiding Symptoms in Patients Undergoing Permanent Prostate Brachytherapy

By Krupski T.   Bissonette E.A.   Petroni G.R.   Theodorescu D.  

European Urology, Vol. 43, Iss. 5, 2003-05 ,pp. : 467-472

Elsevier

Access to resources Recommend Favorite

Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy

By Merrick G.S.   Butler W.M.   Galbreath R.W.   Lief J.H.   Adamovich E.  

Urology, Vol. 60, Iss. 1, 2002-07 ,pp. : 98-103

Elsevier

Access to resources Recommend Favorite

The prognostic importance of prostate specific antigen in the monitorisation of patients undergoing maximum androgen blockade for metastatic prostate cancer

By Kiper Ahmet   Yiğitbası Orhan   Imamoglu Abdurrahim   Tuygun Can   Turan Celaleddin  

International Urology and Nephrology, Vol. 38, Iss. 3-4, 2006-12 ,pp. : 571-576

Springer Publishing Company

Access to resources Recommend Favorite

The impact of prostatectomy and brachytherapy in patients with localized prostate cancer

By Reis Felipe   Netto Nelson   Reinato José   Thiel Marcelo   Zani Emerson  

International Urology and Nephrology, Vol. 36, Iss. 2, 2004-06 ,pp. : 187-190

Springer Publishing Company

Access to resources Recommend Favorite